Orthocell Ltd ORHHF
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- 15,664 / 15,664
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Orthocell Ltd is a regenerative medicine company. The company is engaged in the development and commercialisation of cell therapies and related technologies. Its product includes CelGro is a naturally derived collagen medical device for tissue repair and Ortho-ATI is a first-in-class cell therapy for the treatment of chronic tendon injuries.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- —
- Website
- https://www.orthocell.com.au
Comparables
Valuation
|
Metric
|
ORHHF
|
BLU
|
AUPH
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | — | 5.83 | 1.94 |
Price/Sales | — | — | 4.15 |
Price/Cash Flow | — | — | — |
Price/Earnings
ORHHF
BLU
AUPH
Financial Strength
|
Metric
|
ORHHF
|
BLU
|
AUPH
|
|---|---|---|---|
Quick Ratio | 4.35 | 32.13 | 4.85 |
Current Ratio | 4.60 | 33.42 | 5.50 |
Interest Coverage | — | −1,125.80 | −33.04 |
Quick Ratio
ORHHF
BLU
AUPH
Profitability
|
Metric
|
ORHHF
|
BLU
|
AUPH
|
|---|---|---|---|
Return on Assets (Normalized) | — | −21.75% | −7.67% |
Return on Equity (Normalized) | — | −26.24% | −10.09% |
Return on Invested Capital (Normalized) | — | −24.47% | −11.04% |
Return on Assets
ORHHF
BLU
AUPH
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Wjzghkck | Tbrp | $554.7 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Fpngtkz | Kgwpgtb | $102.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Yqwxdyq | Snnptdy | $97.8 Bil | |
MRNA
| Moderna Inc | Vmnxqphb | Kghns | $41.3 Bil | |
ARGX
| argenx SE ADR | Dckyjbrwc | Nybfl | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Xlgnqxk | Rhjf | $21.0 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Vnbglccnr | Djmnsm | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Lxlvpmhjd | Ttlqdk | $15.4 Bil | |
RPRX
| Royalty Pharma PLC Class A | Zpgtkkrzb | Xzbblfc | $12.5 Bil | |
INCY
| Incyte Corp | Qhbcqgfbn | Pzcymd | $11.6 Bil |